Department of Nursing, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Nursing for Advanced Practice, Department of Integrated Health Sciences, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Nagoya J Med Sci. 2024 May;86(2):201-215. doi: 10.18999/nagjms.86.2.201.
The purpose of this study was to develop and test the reliability and validity of a brief and comprehensive instrument to assess self-management, decision-making, and coping by chronic obstructive pulmonary disease (COPD) patients. A web-based questionnaire was administered to 300 COPD patients and a retest was administered to 100 COPD patients. Cronbach's alpha was used to assess internal consistency, and an intraclass correlation coefficient was calculated to test the reliability of the retest. The convergent and discriminant validities were also examined. Valid responses were obtained from 279 participants in the first survey and 70 participants in the retest. From our analysis, a COPD self-care assessment scale (CSCS) was developed, consisting of seven subscales and 14 items. Cronbach's alpha for the total CSCS score, intraclass correlation coefficient, and scale success rate were 0.80, 0.79, and 100%, respectively. A multivariate analysis showed that CSCS was associated with current smoking (standardized partial regression coefficient [std β] = -0.30; p < 0.001), long-term oxygen therapy (std β = 0.23; p < 0.001), and social support (std β = 0.24; p < 0.001), but not psychological symptoms or quality of life. The CSCS is also useful in assessing self-management, decision-making, and coping in Japanese COPD patients, and the scale has high reliability and validity.
本研究旨在开发和检验一种用于评估慢性阻塞性肺疾病(COPD)患者自我管理、决策和应对能力的简短而全面的工具的信度和效度。通过网络向 300 名 COPD 患者发放问卷,并对其中 100 名患者进行重测。采用克朗巴赫α系数评估内部一致性,计算组内相关系数以检验重测信度。还检验了其收敛和判别效度。首次调查的有效应答者为 279 名,重测的有效应答者为 70 名。分析结果显示,开发出 COPD 自我护理评估量表(CSCS),包括七个分量表和 14 个条目。CSCS 总分的克朗巴赫α系数、组内相关系数和量表成功率分别为 0.80、0.79 和 100%。多变量分析显示,CSCS 与当前吸烟(标准化偏回归系数[std β] = -0.30;p < 0.001)、长期氧疗(std β = 0.23;p < 0.001)和社会支持(std β = 0.24;p < 0.001)相关,但与心理症状或生活质量无关。CSCS 也可用于评估日本 COPD 患者的自我管理、决策和应对能力,该量表具有较高的信度和效度。